Maurer's Healthcare Insight (19)

September 3, 2001
Intercompany Restructuring: Inevitable or Impossible? P. Reed Maurer I talk a lot about achieving critical mass as a key ingredient for success in the Japanese pharmaceutical market. In 2000 four foreign companies were ranked in the top 10 of all...read more